iifl-logo

SBI Healthcare Opportunities Fund G

SBI Healthcare Opportunities Fund G

Fund Name

SBI Mutual Fund

Scheme Name

SBI Healthcare Opportunities Fund G

AMC

SBI Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

04-Jun-1999

Fund Manager

Tanmaya Desai

Net Assets (Rs. cr)

5399.88

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

SBI Healthcare Opportunities Fund G - Nav Details

Nav Date

:  04-Sep-2026

NAV [Rs.]

:  -

Buy/Resale Price [Rs.]

-

Sell/Repurchase Price [Rs.]

-

Entry Load %

Exit Load %

SBI Healthcare Opportunities Fund G- NAV Chart

SBI Healthcare Opportunities Fund G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
-0.04
1.61
13.93
21.87
20.97
23.75
17.26
15.7
Category Avg
-0.34
1.47
11.77
18.97
17.78
21.82
14.44
17.89
Category Best
0.53
4.71
15.22
26.61
28.01
25.46
18.5
32.01
Category Worst
-0.82
-1.13
6.43
8
4.92
17.86
11.28
6.23

SBI Healthcare Opportunities Fund G- Latest Dividends

No Records Found

SBI Healthcare Opportunities Fund G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
Syngene Intl.13,36,533
Health.Global5,88,982

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology12.723450000686.72
EquityDivi's Lab.Pharmaceuticals & Biotechnology7.46500000402.80
EquityAcutaas ChemicalPharmaceuticals & Biotechnology5.17900000279.44
EquityCiplaPharmaceuticals & Biotechnology5.071860000274.01
EquityApollo HospitalsHealthcare Services4.98300000268.71
EquityTorrent Pharma.Pharmaceuticals & Biotechnology4.74500000256.14
EquityMax HealthcareHealthcare Services4.582250000247.16
EquityLaurus LabsPharmaceuticals & Biotechnology4.041200000217.94
EquityAurobindo PharmaPharmaceuticals & Biotechnology3.861320000208.58
EquityAster DM QualityHealthcare Services3.652400000197.31
EquityBioconPharmaceuticals & Biotechnology2.963750000159.63
EquityJupiter Life LinHealthcare Services2.884688843155.43
EquityAnthem BiosciencPharmaceuticals & Biotechnology2.821880000152.12
EquityGland PharmaPharmaceuticals & Biotechnology2.78600000150.17
EquityFortis Health.Healthcare Services2.631500000141.75
EquitySai LifePharmaceuticals & Biotechnology2.441000000131.51
EquityAether Industri.Chemicals & Petrochemicals2.28800000123.16
EquitySudeep PharmaChemicals & Petrochemicals2.221360000119.82
EquityPoly MedicureHealthcare Equipment & Supplies2.02640000108.92
EquityKrishna Institu.Healthcare Services1.981331126107.11
EquityAjanta PharmaPharmaceuticals & Biotechnology1.93300000103.95
EquityConcord BiotechPharmaceuticals & Biotechnology1.89720000102.29
EquityMankind PharmaPharmaceuticals & Biotechnology1.8340000098.78
EquityLupinPharmaceuticals & Biotechnology1.7940000096.60
EquityCohance LifePharmaceuticals & Biotechnology1.73220000093.51
EquityGlobal HealthHealthcare Services1.6764000089.95
EquityNephrocare HealtHealthcare Services1.2095289964.95
EquityDr Lal PathlabsHealthcare Services1.0630000057.15
EquityAbbott IndiaPharmaceuticals & Biotechnology1.032000055.60
EquitySyngene Intl.Healthcare Services0.96133653351.57
EquityRainbow Child.Healthcare Services0.8530000045.76
EquityHealth.GlobalHealthcare Services0.7358898239.53
EquityGufic BioSciencePharmaceuticals & Biotechnology0.3650000019.49

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
SBI Mutual Fund
Incorporation Date:
07-Feb-1992
Total Assets Managed (Cr.):
12,81,380.67
Trustee/s:
Sandra Martyres, Bharati Rao, Smt. Manju Agarwal, SBI Mutual Fund Trustee C, Richard Mendonca, Mr. Dhruv Prakash
Chairman:
NA
CEO / MD:
Debasish Mishra
CIO:
NA
President:
NA
Director/s:
Om Prakash Gahrotra, Dr. Prafulla Agnihotri, Mrs. Madhu Dubhashi
Compliance Officer/s:
NA
Investor Service Officer/s:
NA
Fund Manager/s:
Tanmaya Desai
Auditors:
Sudit K Parekh & Co, M/S Chandabhoy&Jassoobhoy

OTHER INFORMATION

Registered Office:
9th Floor,Crescenzo, C-39&39, G Block, Bandra kurla complex, Bandra (east), Mumbai-400 051.
Contact Nos:
022-61793000
Fax:
022-67425687
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.